You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our anti-DLL4 (DLL4) Antibodies

Full name:
anti-delta-Like 4 Antibodies (DLL4)
On are 167 delta-Like 4 (DLL4) Antibodies from 23 different suppliers available. Additionally we are shipping DLL4 Kits (23) and DLL4 Proteins (23) and many more products for this protein. A total of 223 DLL4 products are currently listed.
Delta4, hdelta2, si:ch211-244p18.5, zgc:136596
list all antibodies Gene Name GeneID UniProt
DLL4 54567 Q9NR61
DLL4 54485 Q9JI71
DLL4 311332  

Show all species

Show all synonyms

Most Popular Reactivities for anti-DLL4 (DLL4) Antibodies

Select your species and application

anti-Human DLL4 Antibodies:

anti-Mouse (Murine) DLL4 Antibodies:

anti-Rat (Rattus) DLL4 Antibodies:

All available anti-DLL4 Antibodies

Go to our pre-filtered search.

Top referenced anti-DLL4 Antibodies

  1. Human Polyclonal DLL4 Primary Antibody for ELISA, IHC - ABIN269907 : Lauret, Catelain, Titeux, Poirault, Dando, Dorsch, Villeval, Groseil, Vainchenker, Sainteny, Bennaceur-Griscelli: Membrane-bound delta-4 notch ligand reduces the proliferative activity of primitive human hematopoietic CD34+CD38low cells while maintaining their LTC-IC potential. in Leukemia 2004 (PubMed)
    Show all 13 references for ABIN269907

  2. Chimpanzee Polyclonal DLL4 Primary Antibody for EIA, IHC (p) - ABIN401283 : Dorsch, Zheng, Yowe, Rao, Wang, Shen, Murphy, Xiong, Shi, Gutierrez-Ramos, Fraser, Villeval: Ectopic expression of Delta4 impairs hematopoietic development and leads to lymphoproliferative disease. in Blood 2002 (PubMed)
    Show all 5 references for ABIN401283

  3. Human Monoclonal DLL4 Primary Antibody for FACS, ELISA - ABIN969514 : Al Haj Zen, Oikawa, Bazan-Peregrino, Meloni, Emanueli, Madeddu: Inhibition of delta-like-4-mediated signaling impairs reparative angiogenesis after ischemia. in Circulation research 2010 (PubMed)
    Show all 2 references for ABIN969514

  4. Human Monoclonal DLL4 Primary Antibody for EIA, WB - ABIN1106965 : Sheldon, Heikamp, Turley, Dragovic, Thomas, Oon, Leek, Edelmann, Kessler, Sainson, Sargent, Li, Harris: New mechanism for Notch signaling to endothelium at a distance by Delta-like 4 incorporation into exosomes. in Blood 2010 (PubMed)
    Show all 2 references for ABIN1106965

  5. Human Monoclonal DLL4 Primary Antibody for IHC, ELISA - ABIN969515 : Jubb, Soilleux, Turley, Steers, Parker, Low, Blades, Li, Allen, Leek, Noguera-Troise, Gatter, Thurston, Harris: Expression of vascular notch ligand delta-like 4 and inflammatory markers in breast cancer. in The American journal of pathology 2010 (PubMed)
    Show all 2 references for ABIN969515

  6. Human Polyclonal DLL4 Primary Antibody for IHC, ELISA - ABIN129625 : Zhang, Zeng, Zhang, Jiao, Li, Jing, Ouyang, Yuan, Chai, Che, Zhang, Yang: Suppressor of cytokine signaling 3 promotes bone marrow cells to differentiate into CD8+ T lymphocytes in lung tissue via up-regulating Notch1 expression. in Cancer research 2009 (PubMed)
    Show all 2 references for ABIN129625

  7. Human Polyclonal DLL4 Primary Antibody for IHC, ELISA - ABIN1043880 : Indraccolo, Minuzzo, Masiero, Pusceddu, Persano, Moserle, Reboldi, Favaro, Mecarozzi, Di Mario, Screpanti, Ponzoni, Doglioni, Amadori: Cross-talk between tumor and endothelial cells involving the Notch3-Dll4 interaction marks escape from tumor dormancy. in Cancer research 2009 (PubMed)
    Show all 2 references for ABIN1043880

  8. Cow (Bovine) Polyclonal DLL4 Primary Antibody for WB - ABIN2783745 : Williams, Segarra, Sierra, Sainson, Tosato, Harris: Regulation of CXCR4 by the Notch ligand delta-like 4 in endothelial cells. in Cancer research 2008 (PubMed)

  9. Mouse (Murine) Monoclonal DLL4 Primary Antibody for ICC, FACS - ABIN1169261 : Fiorini, Ferrero, Merck, Favre, Pierres, Luther, MacDonald: Cutting edge: thymic crosstalk regulates delta-like 4 expression on cortical epithelial cells. in Journal of immunology (Baltimore, Md. : 1950) 2008 (PubMed)

More Antibodies against DLL4 Interaction Partners

Human delta-Like 4 (DLL4) interaction partners

  1. Low DLL4 abundance in tumour cells may predict the benefit from adjuvant gemcitabine therapy after PDAC resection.

  2. Angiogenesis in Infantile haemangioma (IH) appears to be controlled by DLL4 within the endothelium in a VEGF-A (show VEGFA Antibodies) isoform-dependent manner, and in perivascular cells in a VEGF (show VEGFA Antibodies)-independent manner. The contribution of VEGF-A (show VEGFA Antibodies) isoforms to disease progression also indicates that IH may be associated with altered splicing.

  3. Dll4 modulates liver inflammatory response by down-regulating chemokine (show CCL1 Antibodies) expression

  4. Positive Jagged1 (show JAG1 Antibodies) and DLL4 expression is closely correlated with severe clinicopathological characteristics and poor prognosis in patients with pancreatic ductal carcinoma.

  5. Data show that the IgA/delta-like protein 4 (Delta-4)/Notch (show NOTCH1 Antibodies) receptor (Notch (show NOTCH1 Antibodies)) axis is not observed in IgG-dendritic cells (DCs).

  6. Data suggest that the vascular DLL4-Notch4 signaling and VEGF signaling complementing each other plays an important role in the progression of tumor angiogenesis in primary glioblastoma.

  7. our data indicate that high DLL4 expression predicts pelvic lymph node metastasis and poor survival in cervical cancer. Therefore, DLL4 may be a potential clinical diagnostic marker for patients with early-stage cervical cancer.

  8. Cyclic AMP Response Element Binding Protein Mediates Pathological Retinal Neovascularization via Modulating DLL4-NOTCH1 (show NOTCH1 Antibodies) Signaling

  9. DLL4 and JAG1 (show JAG1 Antibodies) may have opposing effects on tumor angiogenesis in glioblastoma.

  10. Data indicate the role for altered forkhead box C2 (FoxC2)-Delta-like (show DLK1 Antibodies) ligand 4 (Dll4)signaling in structural alterations of saphenous veins in patients with varicose veins.

Mouse (Murine) delta-Like 4 (DLL4) interaction partners

  1. The results demonstrate that the Vegf (show VEGFA Antibodies)-Dll4/Notch (show NOTCH1 Antibodies) feedback system normally operates to generate heterogeneity between endothelial cells driving blood vessel branching, whilst synchronization drives vessel expansion.

  2. Dll4 modulates liver inflammatory response by down-regulating chemokine (show CCL1 Antibodies) expression

  3. Cyclic AMP Response Element Binding Protein Mediates Pathological Retinal Neovascularization via Modulating DLL4-NOTCH1 (show NOTCH1 Antibodies) Signaling

  4. miRNA-30e targeted the 3'-UTR (show UTS2R Antibodies) of Dll4 and downregulated Dll4 expression

  5. Dll4/Notch (show NOTCH1 Antibodies) signaling and HIF-1alpha (show HIF1A Antibodies) are closely related to lymphangiogenesis in dry eye-induced lacrimal glands.

  6. Dll4-induced Notch1 (show NOTCH1 Antibodies) activity is required to specify the arterial programme in the aorta-gonad-mesonephros embryonic region.

  7. Tumor promoting effect of low-dosage inhibition needs to be considered when implementing Delta-like (show DLK1 Antibodies) 4 targeting therapies.

  8. The heart defects in Dll4-/- embryos are consistent with primary defects in vessel patterning.

  9. DLL4 is an efficient cis (show CISH Antibodies)-inhibitor of Notch (show NOTCH1 Antibodies) signaling during embryogenesis.

  10. Macrophage Dll4 promotes lesion development in vein grafts via macrophage activation and crosstalk between macrophages and smooth muscle cells.

Zebrafish delta-Like 4 (DLL4) interaction partners

  1. Thsd7a (show THSD7A Antibodies) could regulate ISV angiogenesis via Notch (show NOTCH1 Antibodies)-dll4 signaling. Thus, Thsd7a (show THSD7A Antibodies) is a potent angioneurin involved in the development of both neural and vascular systems.

  2. show that blood flow suppresses vascular Notch (show NOTCH1 Antibodies) signalling via down-regulation of dll4

  3. Microinjection of miR (show MYLIP Antibodies)-30 mimics into zebrafish embryos resulted in suppression of dll4 and subsequent excessive sprouting of intersegmental vessels and reduction in dorsal aorta diameter.

  4. Notch (show NOTCH1 Antibodies) signalling pathway mutants Ectopic filopodia were also observed on the inter-somitic vessels of Notch (show NOTCH1 Antibodies) signalling pathway mutants. Ectopic filopodia are not due to loss of dll4.

  5. These studies imply critical roles for Dll4/Notch (show NOTCH1 Antibodies) signaling in the formation and wiring of the lymphatic network.

  6. Dll4-Notch signalling acts as an angiogenic ;off' switch by making endothelial cells unresponsive to Vegf.

  7. Vegfc (show VEGFC Antibodies)/Flt4 (show FLT4 Antibodies) signalling is suppressed by Dll4 in developing zebrafish intersegmental arteries.

DLL4 Antigen Profile

Antigen Summary

This gene is a homolog of the Drosophila delta gene. The delta gene family encodes Notch ligands that are characterized by a DSL domain, EGF repeats, and a transmembrane domain.

Alternative names and synonyms associated with DLL4

  • delta-like 4 (Drosophila) (DLL4) antibody
  • delta-like 4 (Drosophila) (Dll4) antibody
  • delta-like 4 (Drosophila) (dll4) antibody
  • Delta4 antibody
  • hdelta2 antibody
  • si:ch211-244p18.5 antibody
  • zgc:136596 antibody

Protein level used designations for anti-delta-Like 4 (DLL4) Antibodies

delta-like protein 4 , delta 4 , delta ligand 4 , delta-like 4 homolog , delta-like 4 protein , delta4 , drosophila Delta homolog 4 , notch ligand DLL4 , notch ligand delta-2

100057073 Equus caballus
100152163 Sus scrofa
54567 Homo sapiens
54485 Mus musculus
311332 Rattus norvegicus
453344 Pan troglodytes
607575 Canis lupus familiaris
518746 Bos taurus
563920 Danio rerio
Selected quality suppliers for anti-DLL4 (DLL4) Antibodies
Did you look for something else?